Commit To Buy Monte Rosa Therapeutics At $5, Earn 21.2% Annualized Using Options
April 12, 2024 at 11:33 AM EDT
Investors eyeing a purchase of Monte Rosa Therapeutics Inc (GLUE) stock, but tentative about paying the going market price of $7.19/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $5 strike, which has a bid at the time of this writing of 55 cents..